Search results for "Allergy"

showing 10 items of 3181 documents

Modifications of airway responsiveness to adenosine 5'-monophosphate and exhaled nitric oxide concentrations after the pollen season in subjects with…

2002

s: To determine the effect of cessation of exposure to pollen on airway responsiveness to adenosine 5'-monophosphate (AMP) in subjects with pollen-induced rhinitis, and to explore the relationship between changes in airway responsiveness and changes in exhaled nitric oxide (ENO) levels.Subjects were studied during the pollen season and out of season.Specialist allergy unit in a university hospital.Fourteen subjects without asthma with pollen-induced rhinitis who showed bronchoconstriction in response to methacholine and AMP during the pollen season and 10 healthy nonatopic control subjects.In subjects with pollen-induced rhinitis, ENO concentrations, provocative concentration of agonist cau…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAllergyBronchoconstrictionCritical Care and Intensive Care Medicinemedicine.disease_causeNitric OxideBronchial Provocation TestsNitric oxideCohort Studieschemistry.chemical_compoundInternal medicinePollenForced Expiratory Volumeotorhinolaryngologic diseasesmedicineHumansExpirationMethacholine ChlorideAsthmabusiness.industryfood and beveragesRhinitis Allergic Seasonalrespiratory systemmedicine.diseaseAdenosine Monophosphaterespiratory tract diseasesEndocrinologychemistryBreath TestsSpirometryImmunologyExhaled nitric oxidePollenMethacholineBronchoconstrictionFemalemedicine.symptomBronchial HyperreactivityCardiology and Cardiovascular Medicinebusinessmedicine.drugChest
researchProduct

Nasal allergen provocation with Dermatophagoides pteronyssinus in patients with chronic rhinitis referred to a rhinologic surgical center.

2002

Background Skin tests and specific immunoglobulin (Ig)E determinations identify the presence of some immune response to allergens, but frequently do not correlate to allergic disease in vivo. Objective To compare clinical history, skin tests and specific IgE determinations with the results of nasal provocation tests (NPT) to confirm clinically relevant allergy to Dermatophagoides pteronyssinus (DP) in patients with chronic rhinitis referred to a rhinologic surgical center. Methods Clinical data of 2,194 patients with chronic nasal disorders treated at two rhinologic referral centers between 1992 and 1998 were evaluated. Clinical allergy work-up was routinely performed corresponding to Germa…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAllergyNasal Provocation TestsAdolescentmedicine.medical_treatmentImmunologyProvocation testDiseasemedicine.disease_causeImmunoglobulin ENasal provocation testAllergenImmunopathologymedicineImmunology and AllergyHumansAntigens DermatophagoidesChildAgedGlycoproteinsRhinitisSkin Testsbiologybusiness.industryPyroglyphidaeInfantImmunoglobulin EMiddle Agedbiology.organism_classificationmedicine.diseaseDermatologyChild PreschoolImmunologyChronic Diseasebiology.proteinFemalebusinessAnnals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology
researchProduct

Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma.

2010

Omalizumab is approved for the treatment of severe allergic asthma.To compare the efficacy of omalizumab therapy in patients 50 years or older with patients younger than 50 years.Between November 2005 and November 2007 a total of 174 asthma patients 50 years or older (40.7% male, 51.1% taking oral corticosteroids, and mean [SD] serum IgE level of 315 [353] U/L) and 297 asthma patients younger than 50 years (40.0% male, 50.5% taking oral corticosteroids, and mean [SD] serum IgE level of 363 [431] U/L) who met the European Union criteria for add-on therapy with anti-IgE were treated prospectively with omalizumab for 4 months as part of 2 postmarketing surveillance trials.Compared with the pre…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAllergyPediatricsAdolescentImmunologyPostmarketing surveillanceOmalizumabOmalizumabImmunoglobulin EAntibodies Monoclonal HumanizedGermanymedicineProduct Surveillance PostmarketingImmunology and Allergymedia_common.cataloged_instanceHumansAnti-Asthmatic AgentsEuropean unionAdverse effectChildmedia_commonAsthmaAgedbiologybusiness.industryAge FactorsAntibodies MonoclonalImmunoglobulin EMiddle Agedmedicine.diseaseAsthmaSurgeryDiscontinuationAntibodies Anti-IdiotypicRespiratory Function Testsbiology.proteinDisease ProgressionFemalebusinessmedicine.drugFollow-Up StudiesAnnals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology
researchProduct

Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma.

2002

The ability of omalizumab, an anti-immnoglobulin-E agent, to maintain long-term disease control in patients with moderate-to-severe allergic asthma was investigated in a 24-week double-blind extension to a 28-week core trial. During the extension, 483 of the initial 546 patients were maintained on randomised treatment and the lowest sustainable dose of beclomethasone dipropionate (BDP) as established during the steroid-reduction phase of the core trial. The use of concomitant asthma medication was permitted and investigators were allowed to adjust the BDP dose or switch patients from BDP to other asthma medications if deemed necessary. More omalizumab-treated patients (33.5%) than placebo-t…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAllergyTime FactorsAdolescentOmalizumabOmalizumabImmunoglobulin EPlaceboAntibodies Monoclonal HumanizedSeverity of Illness Indexlaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineHypersensitivityHumansAnti-Asthmatic AgentsAdverse effectChildAsthmaAgedbiologyDose-Response Relationship Drugbusiness.industryBeclomethasoneAntibodies MonoclonalMiddle Agedmedicine.diseaseAsthmaSurgeryAntibodies Anti-IdiotypicTreatment OutcomeConcomitantbiology.proteinFemalebusinessmedicine.drugFollow-Up StudiesThe European respiratory journal
researchProduct

Economic costs associated with acute attacks and long-term management of hereditary angioedema.

2010

Background Hereditary angioedema (HAE) is a rare autosomal dominant disorder characterized by recurrent acute attacks of swelling of the larynx, abdomen, and periphery. Objective To assess the economic burden associated with acute attacks and long-term management of HAE. Methods Burden was assessed via a Web-based survey of HAE patients (≥18 years old) that solicited information on attack characterization, short-term treatment, long-term disease management, impact on work, and patient costs. A standardized instrument, the Work Productivity and Activity Impairment questionnaire, was included to assess impact on work productivity. Standard medical costs and US average wage costs were assigned…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyEmergency Medical Servicesmedia_common.quotation_subjectImmunologyWageDrug CostsIndirect costsCost of IllnessEconomic costSurveys and QuestionnairesLong term managementmedicineImmunology and AllergyHumansDisease management (health)Hospital CostsProductivityhealth care economics and organizationsmedia_commonbusiness.industryAngioedemas HereditaryEmergency departmentHealth Care Costsmedicine.diseaseHospitalizationHealth Care SurveysEmergency medicineHereditary angioedemaAcute DiseasePhysical therapyFemalebusinessAnnals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology
researchProduct

The effect of different periods of argon deaeration on exhaled breath condensate pH.

2011

Exhaled breath condensate (EBC) pH has been considered as a biomarker of airway inflammation in asthma. However, little information is available on the duration of argon deaeration required to achieve a stable pH in EBC samples.To identify differences in EBC pH after argon deaeration for 2, 4, and 8 min.EBC pH was determined in EBC samples from 48 subjects with allergic rhinitis (11 asthmatics) and 14 healthy volunteers without deaeration and after argon deaeration for 2, 4, and 8 min.The mean (95% CI) pH values obtained from samples analyzed after 4 min [7.66 (7.52-7.80)] and 8 min [7.70 (7.55-7.85)] of argon deaeration were significantly less acidic (p.001) than those identified after 2 m…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyGastroenterologyMean differenceDrug Administration ScheduleInternal medicineHealthy volunteersmedicineHypersensitivityImmunology and AllergyHumansExhaled breath condensateArgonAsthmaRhinitisbusiness.industryAirway inflammationHydrogen-Ion Concentrationmedicine.diseaseBreath TestsAnesthesiaPediatrics Perinatology and Child HealthBiomarker (medicine)FemalebusinessBiomarkersThe Journal of asthma : official journal of the Association for the Care of Asthma
researchProduct

Assessment of the reliability, validity, and responsiveness of a Spanish Asthma Quality of Life questionnaire.

1998

A Spanish-language questionnaire designed for measuring the impact of asthma on quality of life in adults was developed. It was derived, by the application of a rigorous translation protocol, from a previously validated, English-language Asthma Quality of Life (AQL) questionnaire which had been developed in Australia. The aim of this study was to evaluate the psychometric properties of the Spanish AQL questionnaire using a cross-sectional and longitudinal design. Two hundred ninety-four clinically stable subjects with asthma (168 women, mean baseline forced expiratory volume in 1 sec [FEV1] = 85% predicted), aged 17-70, attended for the initial baseline assessment. All subjects completed th…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyPsychometricsAdolescentPsychometricsIntraclass correlationCross-sectional studyPhysical examinationCronbach's alphaQuality of lifeSurveys and QuestionnairesmedicineImmunology and AllergyHumansLongitudinal StudiesAsthmaAgedLanguagemedicine.diagnostic_testbusiness.industryConstruct validityReproducibility of ResultsMiddle Agedmedicine.diseaseAsthmaCross-Sectional StudiesSpainPediatrics Perinatology and Child HealthMultivariate AnalysisPhysical therapyQuality of LifeFemalebusinessThe Journal of asthma : official journal of the Association for the Care of Asthma
researchProduct

Subjective symptomatology of asthma: validation of the asthma symptom checklist in an outpatient Spanish population.

1997

The objective of this study was to validate the Asthma Symptom Checklist (ASC) so that it could be reliably used to assess the subjective symptomatology of asthma attacks in our context. Subjective symptomatology of asthma was examined in a group of 100 adult Spanish outpatients (57 women, 43 men; 17-69 years of age) with asthma. All of them completed the modified version of the ASC as well as questionnaires of depression, anxiety, and self-management of asthma (self-efficacy expectancies and health care utilization). Data about duration and severity of asthma, as well as dyspnea and %FEV1, were also recorded. The highest reliability Cronbach alpha indexes were for the panic-fear and fatigu…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtySelf-Evaluation ProgramsAdolescentContext (language use)AnxietyIrritabilitySeverity of Illness IndexSex FactorsCronbach's alphaForced Expiratory VolumeSurveys and QuestionnairesSeverity of illnessOutpatientsmedicineImmunology and AllergyHumansHyperventilationFatigueAsthmaAgedbusiness.industryDepressionConstruct validityMiddle Agedmedicine.diseaseChecklistAsthmaIrritable Moodrespiratory tract diseasesAirway ObstructionSelf CareDyspneaSpainPediatrics Perinatology and Child HealthPhysical therapyAnxietyPanic DisorderFemalemedicine.symptombusinessDelivery of Health CareThe Journal of asthma : official journal of the Association for the Care of Asthma
researchProduct

Does the frequency of switching inhalers represent a predictive factor of exacerbation in asthma?

2020

Objective: Management of asthma includes monitoring of inhaler technique and level of adherence to treatment. Both factors could be influenced by high frequency of switching inhaler devices. We explored whether switching inhalers is an independent predictive factor of exacerbations. Methods: Data were collected from 2015 to 2017 from the outpatient clinic of asthma at the University of Palermo, Italy. This observational study consisted of two phases: Phase 1 included subjects of at least three visits in the previous year who reported the frequency of inhalers switched; Phase 2 included subjects of at least two visits during the second year, and the rate of switches and exacerbations was rec…

Pulmonary and Respiratory MedicineAdultmedicine.medical_specialtyExacerbationSettore MED/10 - Malattie Dell'Apparato Respiratorioexacerbation: inhaler03 medical and health sciencesYoung Adult0302 clinical medicineAdrenal Cortex HormonesAdministration InhalationmedicineImmunology and AllergyHumans030212 general & internal medicineAnti-Asthmatic AgentsIntensive care medicinedeviceAsthmaAgedAged 80 and overbusiness.industryInhalerNebulizers and VaporizersMiddle Agedmedicine.diseaseAsthmaswitchPredictive factorHospitalization030228 respiratory systemPediatrics Perinatology and Child Healthbusiness
researchProduct

Modifications in forced vital capacity during adenosine monophosphate-induced bronchoconstriction in asthma: relationship with the response to methac…

2009

Background The effect of adenosine monophosphate (AMP) on forced vital capacity (FVC) has never been systematically investigated. Objective To compare methacholine- and AMP-induced changes in FVC, as a marker of air trapping, in asthmatic patients treated and not treated with inhaled corticosteroids (ICSs). Methods Airway responsiveness to equipotent concentrations of AMP and methacholine was obtained in asthmatic patients treated (n = 32) and not treated (n = 18) with ICSs. The response was expressed by the provocation concentration of agonist that caused a decrease in forced expiratory volume in 1 second (FEV 1 ) of 20% (PC 20 ) and by the slope of the FVC values recorded at each step of …

Pulmonary and Respiratory MedicineAgonistAdultMalemedicine.medical_specialtyVital capacityAdolescentmedicine.drug_classBronchoconstrictionImmunologyProvocation testVital CapacityBronchial Provocation TestsFEV1/FVC ratioYoung AdultAdrenal Cortex HormonesInternal medicineForced Expiratory VolumeAdministration InhalationmedicineImmunology and AllergyHumansMethacholine ChlorideAsthmaAgedInhalationbusiness.industryrespiratory systemMiddle Agedmedicine.diseaseAdenosine MonophosphateAsthmarespiratory tract diseasesEndocrinologyBronchoconstrictionMethacholineFemalemedicine.symptombusinessmedicine.drugAnnals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology
researchProduct